Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1980-12-15
1982-11-09
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
2601125S, A61K 3700, C07C10352
Patent
active
043584390
ABSTRACT:
Cyclic peptides of the formula ##STR1## in which trp represents L-Trp, D-Trp, or an analogous radical which carries a halogen atom in the indole nucleus, Ac.sub.A represents hydrogen, or an acyl radical Ac of a carboxylic acid present at the .epsilon.-amino group, A represents L-Phe, D-Phe, L-Phg or D-Phg, or a corresponding radical having a substituted or saturated phenyl ring, and B represents the residue of a .gamma.- or .delta.-amino-lower alkanecarboxylic acid which may carry an optionally substituted cyclic hydrocarbyl radical Ar, and also pharmacologically tolerable salts and therapeutically acceptable complexes thereof can be used as an antidiabetic in an analogous manner to somatostatin. They can be obtained by conventional processes of peptide chemistry, especially by cyclisation of corresponding linear peptides.
REFERENCES:
patent: 3725380 (1973-04-01), Konig et al.
patent: 3862113 (1975-01-01), Riniker et al.
patent: 3872074 (1975-03-01), Konig et al.
patent: 3875207 (1975-04-01), Iselin et al.
patent: 3944590 (1976-03-01), Iselin et al.
patent: 4146612 (1979-03-01), Veber
patent: 4238481 (1980-12-01), Rink et al.
Science 179, 77 (1973).
Kamber Bruno
Rink Hans
Sieber Peter
Almaula Prabodh I.
Ciba-Geigy Corporation
Glynn Michael W.
Phillips Delbert R.
LandOfFree
Cyclooctapeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclooctapeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclooctapeptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-745603